Tag: glaucoma
-
Statin Use Linked to Increased Glaucoma Risk in Hyperlipidemia
Overview: Statins and Eye Health in Hyperlipidemia Emerging research suggests a potential link between statin therapy and an increased risk of ocular hypertension and primary open-angle glaucoma (POAG) among individuals with hyperlipidemia. While statins are widely prescribed to manage cholesterol and reduce cardiovascular risk, some studies indicate that long-term statin use could be associated with…
-
Statin Use Linked to Higher Glaucoma Risk in Hyperlipidemia Patients
Overview: Statins and Eye Health Statins are widely prescribed to manage high cholesterol and reduce cardiovascular risk. In recent research highlighted by Investigative Ophthalmology & Visual Science, scientists explored whether long-term statin use could influence eye health, particularly in people with hyperlipidemia. The study found associations between statin use and higher odds of ocular hypertension…
-
Statin Use and Glaucoma Risk: Ocular Hypertension May Follow Long-Term Therapy
Overview: Statins and Eye Health Statins are widely prescribed to manage high cholesterol and reduce cardiovascular risk. However, emerging findings suggest a potential connection between statin use and certain eye conditions, notably ocular hypertension and primary open-angle glaucoma (POAG). This association appears strongest among individuals with hyperlipidemia and tends to become more evident with longer…
-
Breakthrough Eye Drop Nanomedicine Secures Worldwide Patents
Breakthrough in Eye Care: International Patents for Nanomedicine Eye Drops In a landmark development for ophthalmology and patient care, SETU Researcher Dr. Laurence Fitzhenry and the Ocular Therapeutics Research Group (OTRG) at South East Technological University have secured two international patents for advanced eye drop technology. Granted by the United States and European patent offices,…
-
SETU Researcher Secures International Patents for Breakthrough Eye Drop Technology
SETU researcher earns international patents for revolutionary eye drop technology The healthcare and biotech communities are celebrating after Dr. Laurence Fitzhenry of South East Technological University (SETU) secured two international patents for groundbreaking eye drop technologies. Awarded by both the United States and European patent offices, the patents cover a new generation of nanomedicine eye…